[
  {
    "ts": "2026-02-17T08:33:17+00:00",
    "headline": "What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock?",
    "summary": "Although Intuitive Surgical has lagged the broader market over the past year, analysts remain broadly bullish on the company’s long-term growth outlook.",
    "url": "https://www.barchart.com/story/news/249166/what-are-wall-street-analysts-target-price-for-intuitive-surgical-stock",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "f0390877-b0bf-3bcd-a818-d5626a914bcf",
      "content": {
        "id": "f0390877-b0bf-3bcd-a818-d5626a914bcf",
        "contentType": "STORY",
        "title": "What Are Wall Street Analysts' Target Price for Intuitive Surgical Stock?",
        "description": "",
        "summary": "Although Intuitive Surgical has lagged the broader market over the past year, analysts remain broadly bullish on the company’s long-term growth outlook.",
        "pubDate": "2026-02-17T08:33:17Z",
        "displayTime": "2026-02-17T08:33:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/1ed6dc8fb90e48dcdc048b84bb7630f6",
          "originalWidth": 1253,
          "originalHeight": 836,
          "caption": "Intuitive Surgical Inc location sign-by Sundry Photography via iStock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CUOUDum4Pf_4O_E.qyH7yA--~B/aD04MzY7dz0xMjUzO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/1ed6dc8fb90e48dcdc048b84bb7630f6.cf.webp",
              "width": 1253,
              "height": 836,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JyFOUorHZZW6K7q.PGInVw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/1ed6dc8fb90e48dcdc048b84bb7630f6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/249166/what-are-wall-street-analysts-target-price-for-intuitive-surgical-stock",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-analysts-target-price-083317976.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-17T14:48:00+00:00",
    "headline": "Medtronic Posts Better-Than-Expected Earnings. Here’s Why the Stock Is Falling.",
    "summary": "Medical device maker  Medtronic  reported quarterly earnings and net sales that topped consensus views.  Medtronic  on Tuesday posted fiscal third-quarter adjusted earnings of $1.36 a share, narrowly beating analysts’ forecasts of $1.34.  Medtronic’s profit declined from the same period last year on a non-adjusted basis, slipping to $1.14 billion from $1.29 billion.",
    "url": "https://www.barrons.com/articles/medtronic-earnings-stock-price-9c382730?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "230db64a-3a23-3d05-8231-8bbc82a1e0e1",
      "content": {
        "id": "230db64a-3a23-3d05-8231-8bbc82a1e0e1",
        "contentType": "STORY",
        "title": "Medtronic Posts Better-Than-Expected Earnings. Here’s Why the Stock Is Falling.",
        "description": "",
        "summary": "Medical device maker  Medtronic  reported quarterly earnings and net sales that topped consensus views.  Medtronic  on Tuesday posted fiscal third-quarter adjusted earnings of $1.36 a share, narrowly beating analysts’ forecasts of $1.34.  Medtronic’s profit declined from the same period last year on a non-adjusted basis, slipping to $1.14 billion from $1.29 billion.",
        "pubDate": "2026-02-17T14:48:00Z",
        "displayTime": "2026-02-17T14:48:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/230db64a-3a23-3d05-8231-8bbc82a1e0e1/medtronic-posts.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/9ce73897596e23e997c7d545418b6f01",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bClzgrn6ArwYoA4Rl2bJ1w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/9ce73897596e23e997c7d545418b6f01.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EbKd.Kbis6_lrSq7d4iBHg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/9ce73897596e23e997c7d545418b6f01.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/medtronic-earnings-stock-price-9c382730?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MDT"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-17T14:00:03+00:00",
    "headline": "Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/intuitive-surgical-inc-isrg-attracting-140003160.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "09a5f9e9-de32-38e4-9a86-95f0b48155ff",
      "content": {
        "id": "09a5f9e9-de32-38e4-9a86-95f0b48155ff",
        "contentType": "STORY",
        "title": "Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2026-02-17T14:00:03Z",
        "displayTime": "2026-02-17T14:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ucluz4bedY7Dxd_XS4xCHQ--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Asv6z7WU__xaJFJkAJhxZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/intuitive-surgical-inc-isrg-attracting-140003160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/intuitive-surgical-inc-isrg-attracting-140003160.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-17T16:20:00+00:00",
    "headline": "Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel",
    "summary": "TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.",
    "url": "https://finance.yahoo.com/news/tempus-ai-median-partner-add-162000559.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "64eb3bf0-3015-3edc-a8cd-7097b464156d",
      "content": {
        "id": "64eb3bf0-3015-3edc-a8cd-7097b464156d",
        "contentType": "STORY",
        "title": "Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel",
        "description": "",
        "summary": "TEM teams with Median to add FDA-cleared eyonis LCS to Pixel, boosting AI lung cancer screening and expanding its imaging portfolio.",
        "pubDate": "2026-02-17T16:20:00Z",
        "displayTime": "2026-02-17T16:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574",
          "originalWidth": 620,
          "originalHeight": 343,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N5xEJDQ9Yr4pXNEJ_c.8WA--~B/aD0zNDM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574.cf.webp",
              "width": 620,
              "height": 343,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j8jgIs0er2qzWmssl7aBuQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/00e8f1a41a7bc7b2ecf8d421f3c6f574.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ai-median-partner-add-162000559.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ai-median-partner-add-162000559.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ALMDT.PA"
            },
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "TEM"
            },
            {
              "symbol": "ATRC"
            },
            {
              "symbol": "GEHC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-17T16:12:00+00:00",
    "headline": "QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement",
    "summary": "QuidelOrtho inks Lifotronic supply deal, adding 70+ assays and new analyzer platforms to boost global immunoassay reach and recurring revenue potential.",
    "url": "https://finance.yahoo.com/news/qdel-expands-immunoassay-portfolio-via-161200671.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "07c36955-d481-34d0-9ed4-5e855499fa91",
      "content": {
        "id": "07c36955-d481-34d0-9ed4-5e855499fa91",
        "contentType": "STORY",
        "title": "QDEL Expands Immunoassay Portfolio Via Lifotronic Supply Agreement",
        "description": "",
        "summary": "QuidelOrtho inks Lifotronic supply deal, adding 70+ assays and new analyzer platforms to boost global immunoassay reach and recurring revenue potential.",
        "pubDate": "2026-02-17T16:12:00Z",
        "displayTime": "2026-02-17T16:12:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/54CAf0a.xcVnm138kMlg2g--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Qq8AX6cTgCCg_4Ye3FJ4Gw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/qdel-expands-immunoassay-portfolio-via-161200671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/qdel-expands-immunoassay-portfolio-via-161200671.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "QDEL"
            },
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "GEHC"
            },
            {
              "symbol": "ATRC"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]